Home › NCT06738537
Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse
Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse (PRIMARY SDM)
Who can join
Ages 21 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 21 years and older * Diagnosis of degenerative mitral valve regurgitation Exclusion Criteria: * Non-English speaking * Unable to consent on own behalf * Previous mitral surgery
About the study
This is a qualitative and quantitative study that seeks to obtain information from patients with degenerative mitral valve prolapse and providers regarding factors important in deciding between surgical mitral valve repair (MVR) and transcatheter edge-to-edge repair (TEER). Findings from this study will provide data that can be used to develop decision aids that can assist patients in decision making between these two therapies and assist providers in integrating shared decision making the within the multidisciplinary heart valve team.
What is being tested
- Focus Groups/Quantitative Survey for Patients (other)
- Focus Group/Quantitative Survey for HCPs (other)
- Qualitative Focus Group (other)
Sponsor: Northwell Health · Participants: 150 · Started: Sep 1, 2023
Contact the study team
- Nancy Stone, MEd, NBC-HWC · Phone: 816-932-5367
- Shangyi Liu, MS · Phone: 516-757-5949
Official record on ClinicalTrials.gov — NCT06738537
Locations in the U.S.
| California | Cedars-Sinai Medical Center, Los Angeles |
| Missouri | Saint Luke's Hospital, Kansas City |
| New York | Northwell Health, New York |
| Ohio | Cleveland Clinic, Cleveland |
| West Virginia | West Virginia University Medicine, Morgantown |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.